Cadila Pharmaceuticals marks three years of ThRabis, a three-dose rabies vaccine
ThRabis rollout sees increased vaccine compliance and reduced treatment burden across multiple regions
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
rabies vaccine
Cadila Pharma’s rabies vaccine ‘ThRabis’ receives award at Golden Globe Tigers Awards
ThRabis is a three-dose recombinant nanoparticle-based rabies G protein vaccine
Cadila Pharma launches world’s first novel three-dose rabies vaccine ThRabis
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology
Chiron Behring re-launches its rabies vaccine as ‘Chirorab’
Chiron Behring Vaccines was acquired by Bharat Biotech from GSK in March 2019 and commercial operations were restarted in May 2019